Turning <i>EGFR</i> mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors
Crossref DOI link: https://doi.org/10.1177/1758834017753338
Published Online: 2018-01-22
Published Print: 2018-01
Update policy: https://doi.org/10.1177/sage-journals-update-policy
Hirsh, Vera
Text and Data Mining valid from 2018-01-01